Posts by tag
oncodaily
The Scientists Who Turned Cancer Prevention into a Vaccine: Dr Douglas Lowy and Dr John Schiller
The 2026 Pezcoller Foundation–AACR International Award for Extraordinary Achievement in Cancer Research has recognised two scientists whose discoveries reshaped one of oncology’s greatest ambitions: preventing cancer before it begins. On 9 May, at the Teatro Sociale in Trento, Italy, Dr…
Cancer is Universal. Meaning is Not!
She nodded when I said cancer. Only later did I understand that she had heard something else. The consultation unfolded with clinical precision. The translation was accurate. From a professional perspective, nothing was missing. And yet everything was. When I…
No Woman Left Behind: Dr Miriam Mutebi and the Quest for Equitable Cancer Care in Africa
In a breast clinic in Africa, fear often arrives before diagnosis. Women arrive convinced they have cancer. Some have discovered a lump only days earlier; others have lived with symptoms for years. Many have never been taught breast awareness. Others…
This is WHO
There is a lot being said about the World Health Organization these days. Criticism. Political tensions. Funding crises. Countries leaving. Endless speculation about what WHO is, what it failed to do, and what it should become. Some of that criticism…
CancerWorld #116 (June 2026)
We tend to talk about cancer in the language of progress—new therapies, wider prevention, smarter models of care. It is a comforting vocabulary. It is also incomplete. Progress in oncology is never only scientific. It is institutional, social, and deeply…
Rewriting RAS: A New Targeted Option on the Horizon for Pancreatic Cancer
Metastatic pancreatic cancer remains one of the most treatment-refractory solid tumours in oncology. Despite multiple incremental refinements over the past decade, first-line therapy continues to rely on cytotoxic chemotherapy, most commonly FOLFIRINOX or gemcitabine plus nab-paclitaxel, with limited change in…
Immunotherapy’s Hidden Burden: Rethinking Toxicity in the Era of Breakthroughs
Immunotherapy has redefined cancer care—offering survival where little once existed, and in some cases, the possibility of long-term remission. But as its use expands across tumor types and earlier lines of treatment, a more complex reality is coming into focus:…
After the Bell: Rethinking Cancer Care Beyond Treatment
As cancer survival improves, a critical gap persists: the period after treatment, where psychological distress, identity disruption, and unmet needs remain insufficiently addressed in routine oncology care. A System Designed for Treatment, Not Transition “We have to be next to…
From Silence to Presence: Dr Christian Ntizimira on Reimagining End-of-Life Care
Dr Christian Ntizimira, MD, MMsGHE, Founder and Executive Director of the African Center for Research on End-of-Life Care (ACREOL), and author of “The Safari Concept: An African Framework on End-of-Life Care,” speaks about dignity, suffering, and reimagining care at the…
A Survivor’s Perspective: San Diego’s Rise as a National Cancer Research Hub
How policy, philanthropy, and scientific collaboration are reshaping the cancer research landscape and why early detection can be the difference between life and death. Twenty years ago, I received a diagnosis that changed everything and led me to dedicate the…